Digital nudge aims to speed up genetic testing for lung cancer
NCT ID NCT05853887
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an electronic health record reminder (a 'nudge') can prompt doctors to order genetic tests for patients newly diagnosed with advanced non-small cell lung cancer. The goal is to have test results available before starting treatment, so doctors can choose the best therapy. About 260 patients at several Penn Medicine locations will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Electronic health record nudge (a reminder alert for doctors)
- What this could lead to
- If successful, this could show that simple digital reminders help doctors get genetic test results faster, leading to more personalized treatment for lung cancer patients.
- What could go wrong
- This is a behavioral study, not a drug trial, so it won't directly treat cancer. The nudge may not change doctor behavior significantly, and results may not apply to other hospitals or cancer types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEWLY DIAGNOSED NSCLC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Penn Medicine Cherry Hill
Cherry Hill, New Jersey, 08003, United States
-
Penn Medicine Lancaster General Health
Lancaster, Pennsylvania, 17602, United States
-
Penn Medicine Princeton Health
Plainsboro, New Jersey, 08536, United States
-
Penn Medicine Voorhees
Voorhees Township, New Jersey, 08043, United States
-
Penn Medicine Washington Township
Sewell, New Jersey, 08080, United States
-
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a triple-drug cocktail re-sensitize lung cancer to treatment?
- Could a lung cancer drug designed for one mutation work for another?
- Could chemo plus immunotherapy double the punch against tough lung cancers?
- Should all advanced lung cancer patients get a brain scan? new trial aims to find out
- New hope for tough lung cancer? trial tests targeted drug against chemo
- New combo therapy for lung cancer under Real-World watch